• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[质子泵抑制剂治疗与小肠细菌污染]

[Proton-pump inhibitor therapy and small bowel bacterial contamination].

作者信息

Hamvas József

机构信息

Bajcsy-Zsilinszky Kórház I. Belgyógyászat-Gasztroenterológia Budapest Maglódi út 89-91. 1106.

出版信息

Orv Hetil. 2012 Aug 19;153(33):1287-93. doi: 10.1556/OH.2012.29419.

DOI:10.1556/OH.2012.29419
PMID:22890175
Abstract

There are several causes of small bowel contamination. The effects of the long-term proton pump inhibitor treatment on the development of bowel symptoms and/or small intestinal bacterial overgrowth have been highlighted only in the past decade. The main diagnostic method is the hydrogen breath test that gives quantitative results with a simple, non-invasive procedure. There is a limited number of publications in the literature about the effects of proton pump inhibitor drugs on bowel bacterial milieau. Our results based on the investigations of two medical centres in Budapest show consistency with international data: the positive hydrogen breath test was present in 21% of the population using long-term proton pump inhibitors. In uncomplicated cases, symptom-free condition could be reached with probiotics, whereas in long lasting, chronic small intestinal bacterial overgrowth, antibiotic treatment should be considered. Rifaximin, a non-absorbable antibiotic showed high efficacy in the treatment of small intestinal bacterial overgrowth, with fewer side effects compared to systemic antibiotics.

摘要

小肠污染有多种原因。长期质子泵抑制剂治疗对肠道症状发展和/或小肠细菌过度生长的影响仅在过去十年中得到关注。主要诊断方法是氢呼气试验,该试验通过简单、非侵入性的程序给出定量结果。关于质子泵抑制剂药物对肠道细菌环境影响的文献报道数量有限。我们基于布达佩斯两个医学中心的调查结果与国际数据一致:在长期使用质子泵抑制剂的人群中,21%的人氢呼气试验呈阳性。在无并发症的情况下,使用益生菌可实现无症状状态,而在持久的慢性小肠细菌过度生长中,则应考虑抗生素治疗。利福昔明是一种不可吸收的抗生素,在治疗小肠细菌过度生长方面显示出高效性,与全身用抗生素相比副作用更少。

相似文献

1
[Proton-pump inhibitor therapy and small bowel bacterial contamination].[质子泵抑制剂治疗与小肠细菌污染]
Orv Hetil. 2012 Aug 19;153(33):1287-93. doi: 10.1556/OH.2012.29419.
2
A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole.益生菌治疗质子泵抑制剂治疗小儿小肠细菌过度生长的双盲安慰剂对照随机试验
J Pediatr (Rio J). 2013 Jul-Aug;89(4):381-7. doi: 10.1016/j.jped.2012.12.005. Epub 2013 Jun 21.
3
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.利福昔明(一种不被吸收的口服抗生素)治疗小肠细菌过度生长的疗效。
Am J Med Sci. 2007 May;333(5):266-70. doi: 10.1097/MAJ.0b013e3180536784.
4
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.利福昔明与金霉素在小肠细菌过度生长短期治疗中的比较
Aliment Pharmacol Ther. 2000 May;14(5):551-6. doi: 10.1046/j.1365-2036.2000.00751.x.
5
Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.质子泵抑制剂治疗期间小肠细菌过度生长的发生率增加。
Clin Gastroenterol Hepatol. 2010 Jun;8(6):504-8. doi: 10.1016/j.cgh.2009.12.022. Epub 2010 Jan 6.
6
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.高剂量利福昔明治疗小肠细菌过度生长
Aliment Pharmacol Ther. 2007 Apr 1;25(7):781-6. doi: 10.1111/j.1365-2036.2007.03259.x.
7
Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin.用利福昔明(一种不可吸收的利福霉素)治疗小肠细菌过度生长。
J Int Med Res. 1988 Jul-Aug;16(4):312-6. doi: 10.1177/030006058801600410.
8
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.小肠细菌过度生长的抗生素治疗:利福昔明与甲硝唑对比
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):111-6.
9
Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test.通过H2-葡萄糖呼气试验评估利福昔明对克罗恩病肠道细菌过度生长的影响。
Curr Med Res Opin. 2000;16(1):14-20. doi: 10.1185/0300799009117003.
10
Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.小肠细菌过度生长在肠易激综合征中产生症状,利福昔明可改善这些症状。一项初步研究。
Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.

引用本文的文献

1
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.肠道细菌过度生长:发病机制与临床意义。
Ther Adv Chronic Dis. 2013 Sep;4(5):223-31. doi: 10.1177/2040622313496126.